Birgit Gruenberger

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Nature Medicine · 2022 · 374 citations · Full text

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner et al. · The Lancet Oncology · 2010 · 243 citations

Gastrointestinal Oncology, Medicine, Biliary Cancer +7

Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases

Markus Klinger, Sandra Eipeldauer, Stefan Hacker et al. · European Journal of Surgical Oncology · 2009 · 157 citations

Hepatology, Gastrointestinal Oncology, Neoadjuvant Xelox/folfox Therapy +11

Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma

Dietmar Tamandl, Beata Herberger, Birgit Gruenberger et al. · Annals of Surgical Oncology · 2008 · 154 citations

Surgical Oncology, Hepatology, Medicine +10

Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy

Dietmar Tamandl, Markus Klinger, Sandra Eipeldauer et al. · Annals of Surgical Oncology · 2010 · 133 citations

Surgical Oncology, Hepatology, Neoadjuvant Chemotherapy +12